Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1
- PMID: 8845307
Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1
Abstract
Terminal differentiation of cultured myocytes requires withdrawal of the cells from the cell cycle. Constitutive overexpression of several oncogenes in myoblasts can inhibit in vitro myogenesis. Here we studied the role of the cellular transcription factor E2F1 on myogenic differentiation. E2F1 expression is irreversibly down-regulated during differentiation of C2C12 myocytes. Furthermore, deregulated E2F1 expression in C2C12 cells prevented myogenic differentiation. This inhibition of myogenesis was associated with the repression of myogenin expression and an elevated cyclin D1 expression. Moreover, E2F1-overexpressing myocytes failed to exit the cell cycle under differentiation conditions. These results are consistent with the notion that E2F1 can function as an oncogene and further suggest that E2F1 down-regulation is required for myogenic differentiation.
Similar articles
-
E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis.Dev Biol. 2000 Nov 1;227(1):8-41. doi: 10.1006/dbio.2000.9892. Dev Biol. 2000. PMID: 11076674
-
MyoD activity upregulates E2F1 and enhances transcription from the cyclin E promoter in differentiating myoblasts lacking a functional retinoblastoma protein.Exp Cell Res. 2001 Oct 1;269(2):301-11. doi: 10.1006/excr.2001.5318. Exp Cell Res. 2001. PMID: 11570822
-
Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.Oncogene. 1998 May 14;16(19):2489-501. doi: 10.1038/sj.onc.1201773. Oncogene. 1998. PMID: 9627115
-
Role of E2F1 in apoptosis: a case study in feedback loops.Cell Cycle. 2004 Jun;3(6):729-32. Epub 2004 Jun 6. Cell Cycle. 2004. PMID: 15107604 Review.
-
Transcription factors in skeletal myogenesis of vertebrates.Results Probl Cell Differ. 2002;38:109-26. doi: 10.1007/978-3-540-45686-5_5. Results Probl Cell Differ. 2002. PMID: 12132391 Review. No abstract available.
Cited by
-
Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases.Proc Natl Acad Sci U S A. 2002 May 28;99(11):7757-62. doi: 10.1073/pnas.112218599. Proc Natl Acad Sci U S A. 2002. PMID: 12032356 Free PMC article.
-
Subcellular compartmentalization of E2F family members is required for maintenance of the postmitotic state in terminally differentiated muscle.J Cell Biol. 2000 Mar 20;148(6):1187-201. doi: 10.1083/jcb.148.6.1187. J Cell Biol. 2000. PMID: 10725332 Free PMC article.
-
Setdb1 is required for myogenic differentiation of C2C12 myoblast cells via maintenance of MyoD expression.Mol Cells. 2015 Apr;38(4):362-72. doi: 10.14348/molcells.2015.2291. Epub 2015 Feb 25. Mol Cells. 2015. PMID: 25715926 Free PMC article.
-
Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo.J Clin Invest. 1997 Dec 1;100(11):2722-8. doi: 10.1172/JCI119817. J Clin Invest. 1997. PMID: 9389735 Free PMC article.
-
Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation.Mol Cell Biol. 1996 Dec;16(12):7043-53. doi: 10.1128/MCB.16.12.7043. Mol Cell Biol. 1996. PMID: 8943359 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials